JP2001199873A - Composition for external use - Google Patents

Composition for external use

Info

Publication number
JP2001199873A
JP2001199873A JP2000043474A JP2000043474A JP2001199873A JP 2001199873 A JP2001199873 A JP 2001199873A JP 2000043474 A JP2000043474 A JP 2000043474A JP 2000043474 A JP2000043474 A JP 2000043474A JP 2001199873 A JP2001199873 A JP 2001199873A
Authority
JP
Japan
Prior art keywords
extract
melanin
acid
composition
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000043474A
Other languages
Japanese (ja)
Inventor
Masaaki Okubo
昌旺 大久保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000043474A priority Critical patent/JP2001199873A/en
Publication of JP2001199873A publication Critical patent/JP2001199873A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a composition for external use capable of solving the problem that, although a melanin suppressing composition for external use in a conventional beautifying cosmetic or the like is compounded with a melanin formation suppressing component, the actual processes of the formation and distribution of melanin in the skin are very complicated, and even a cosmetic prepared by singly compounding a component which can effectively inhibit or suppress one mechanism of the formation of melanin cannot exhibit practical beautifying effect such as the discoloration or disappearance of pigment deposition effectively sufficiently in a short time. SOLUTION: A cosmetic prepared by compounding a component having melanin formation suppressing activity, a component having inflammatory effect and a component having keratin removal stimulating activity, together. This cosmetic can reduce or remove pigment deposition quickly and effectively.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明はメラニン生成抑制剤と抗
炎症剤及び角質剥離促進剤を同時に配合することを特徴
とする主に皮膚の美白を目的とした化粧料、薬用化粧料
等の外用組成物及び美白方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the external use of cosmetics, medicated cosmetics and the like, mainly for skin whitening, characterized by simultaneously combining a melanin production inhibitor, an anti-inflammatory agent and a keratin exfoliation promoter. Compositions and methods for whitening.

【0002】[0002]

【従来の技術】これまでの美白化粧料は、専らメラニン
の生成を抑制する成分を配合することが行われてきた。
しかしながら実際の皮膚におけるメラニンの生成ならび
にその分配過程が非常に複雑であり、例えメラニン生成
の1機序を効果的に阻害、抑制し得る成分を単独で配合
した化粧料であっても、色素沈着の退色や消失という現
実の美白効果を短期間に効果的に発揮するには未だ満足
できるものはなかった。
2. Description of the Related Art Conventionally, whitening cosmetics have been solely blended with components that suppress the production of melanin.
However, the production and distribution process of melanin in the actual skin is very complicated, and even if a cosmetic contains only a component that can effectively inhibit or suppress one mechanism of melanin production, pigmentation may occur. There was still no satisfactory way to effectively exert the real whitening effect of fading or disappearing in a short period of time.

【0003】[0003]

【発明が解決しようとする課題】本発明は、従来の美白
化粧料等の美白外用剤では不可能であった短期間に効果
的にメラニン色素沈着を退色あるいは消失し得る皮膚の
美白を目的とした外用組成物及びそれを利用した美白方
法を提供するものである。
SUMMARY OF THE INVENTION An object of the present invention is to provide a skin whitening agent capable of effectively fading or eliminating melanin pigmentation in a short period of time, which was impossible with conventional whitening preparations such as whitening cosmetics. And a whitening method using the same.

【0004】本発明者らは色素沈着の軽減あるいは消失
について鋭意研究を重ねた結果、驚くべきことにメラニ
ン生成抑制作用を有する成分と抗炎症作用を有する成分
ならびに角質剥離促進作用を有する成分を同時に配合し
た化粧料が色素沈着を可及的すみやかにかつ効果的に退
色あるいは消失し得ることを見出し、本発明を完成する
に至った。
The present inventors have conducted intensive studies on the reduction or elimination of pigmentation. As a result, surprisingly, a component having an inhibitory action on melanin production, a component having an anti-inflammatory action and a component having an action on promoting exfoliation of keratin were simultaneously obtained. The present inventors have found that the formulated cosmetics can discolor or eliminate pigmentation as quickly and effectively as possible, and have completed the present invention.

【0005】[0005]

【課題を解決するための手段】本発明は、メラニン生成
抑制作用を有する成分と抗炎症作用を有する成分ならび
に角質剥離促進作用を有する成分を同時に配合した化粧
料は、可及的速やかにかつ効果的に色素沈着を軽減ある
いは消失させて、本来美白化粧料に期待される効果を遺
憾なく発揮し得るものである。
SUMMARY OF THE INVENTION The present invention provides a cosmetic composition containing a component having an inhibitory action on melanin production, a component having an anti-inflammatory action and a component having an action on promoting exfoliation at the same time. By reducing or eliminating pigmentation, the effect expected of whitening cosmetics can be fully exhibited.

【0006】本発明の外用組成物が従来の美白剤に比較
し効果的であるのは以下のメカニズムが考えられてい
る。即ち、色索沈着の原因物質であるメラニンの合成に
おける初期段階に大きく関与する炎症性情報伝達物質の
生成を抗炎症剤により抑制し、かつメラニン合成細胞で
ある色素細胞の働きをメラニン生成抑制成剤により制御
するとともに、既に色素細胞から角質細胞へと分配され
たメラニンに対しては皮膚から角質自身の剥離を角質剥
離剤により促進することで従来の美白剤に比して突出し
た色素沈着の軽減あるいは消失効果を奏するものであ
る。
The following mechanism is considered to make the composition for external use of the present invention more effective than conventional whitening agents. That is, the production of inflammatory signaling substances, which are greatly involved in the initial stage of the synthesis of melanin, the causative substance of color cord deposition, is suppressed by an anti-inflammatory agent, and the action of pigment cells, which are melanin-synthesizing cells, is suppressed by melanin production. In addition to controlling by the agent, the melanin already distributed from the pigment cells to the keratinocytes promotes exfoliation of the keratin itself from the skin with the keratin exfoliating agent, which results in the formation of pigmentation that is more prominent than conventional whitening agents. It has a reducing or eliminating effect.

【0007】[0007]

【発明の実施の形態】本発明の化粧料は、メラニン生成
抑制作用を有する成分と抗炎症作用を有する成分ならび
に角質剥離促進作用を有する成分を同時に配合ことを特
徴とする。
BEST MODE FOR CARRYING OUT THE INVENTION The cosmetic of the present invention is characterized in that a component having an inhibitory action on melanin production, a component having an anti-inflammatory action and a component having an action on promoting exfoliation of keratin are simultaneously added.

【0008】本発明のメラニン生成抑制剤は、例えばコ
ウジ酸、アルブチン、ビタミンCおよびその誘導体、例
えばアスコルビン酸−2−グルコシド、アスコルビン酸
−2−リン酸マグネシウム又はナトリウム、アスコルビ
ン酸パルミテート又はステアレート、エラグ酸、ソウハ
クヒ、レゾルシン誘導体、プラセンタエキス、クワエキ
ス、コメハイガエキス、カミツレエキス、コメヌカエキ
ス等メラニン生成抑制作用の知られている成分のから選
択される単体又は複合物であれば良く、好ましくは好ま
しくはビタミンCおよびその誘導体、コメヌカエキスで
ある。
The melanogenesis inhibitors of the present invention include, for example, kojic acid, arbutin, vitamin C and derivatives thereof such as ascorbic acid-2-glucoside, magnesium or sodium ascorbic acid-2-phosphate, ascorbic acid palmitate or stearate, Ellagic acid, soybean sprouts, resorcinol derivatives, placenta extract, mulberry extract, rice haiga extract, chamomile extract, rice bran extract, etc. Vitamin C and its derivatives, rice bran extract.

【0009】本発明の抗炎症剤は、グリチルリチン酸誘
導体、グリチルリチン酸ナトリウム又はカリウム、カン
ゾウエキス、インドメタシン、アスピリン、アラントイ
ン、カンゾウエキス、シャクヤクエキス、ゲンチアナエ
キス、センブリエキス、ニンジンエキス等抗炎症作用の
知られている成分のから選択される単体又は複合物であ
れば良く、好ましくは好ましくはカンゾウエキス、シャ
クヤクエキス、ニンジンエキスである。
[0009] The anti-inflammatory agent of the present invention includes a glycyrrhizic acid derivative, sodium or potassium glycyrrhizinate, licorice extract, indomethacin, aspirin, allantoin, licorice extract, peony extract, gentian extract, assembly extract, carrot extract and the like. It may be a simple substance or a compound selected from the components described above, and preferably a liquorice extract, a peony extract, and a carrot extract.

【0010】本発明の角質剥離剤とは、グリコール酸、
乳酸、クエン酸、コハク酸、酒石酸、リンゴ酸、αヒド
ロキシ酸およびそれらの塩類、乳酸菌醗酵液等角質剥離
作用の知られている成分のから選択される単体又は複合
物であれば良く、好ましくは好ましくは乳酸、乳酸含有
菌醗酵液である。
[0010] The exfoliating agent of the present invention includes glycolic acid,
Lactic acid, citric acid, succinic acid, tartaric acid, malic acid, α-hydroxy acids and salts thereof, may be a simple substance or a compound selected from components having a known exfoliating action such as fermented lactic acid bacteria, and preferably Lactic acid and a lactic acid-containing bacterial fermentation solution are preferred.

【0011】本発明におけるメラニン生成抑制成剤と抗
炎症剤と角質剥離剤の3成分の添加濃度は、各成分の外
用組成物中の重量%は、0.1〜50.0重量%の範囲
であればよい。
In the present invention, the addition concentration of the three components of the melanin production-inhibiting agent, the anti-inflammatory agent and the exfoliating agent is preferably in the range of 0.1 to 50.0% by weight in the external composition. Is good enough.

【0012】本発明の外用組成物によって日焼けによる
しみそばかすを予防するなどの良好な美白作用を得よう
とするには、上記の範囲で調整した本発明の外用剤を1
日当たり1日当たり0.01〜1ml/平方cmの濃度
で皮膚に塗布することが望ましい。
In order to obtain a good whitening effect such as prevention of spots and freckles due to sunburn with the composition for external use of the present invention, the external preparation of the present invention adjusted in the above range should be prepared in the following manner.
It is desirable to apply to the skin at a concentration of 0.01 to 1 ml / cm 2 per day per day.

【0013】本発明の外用剤としては、軟膏、クリー
ム、ローション、化粧水、乳液、エッセンス、リップク
リーム、ゲル剤、マスク、パック、ファンデーション、
口紅、石鹸、ボディーシャンプー、シャンプー、リン
ス、育毛剤、整髪剤、染毛剤、入浴剤、歯磨き、うがい
薬、絆創膏、貼布剤等様々な剤形に配合することができ
る。
The external preparation of the present invention includes ointments, creams, lotions, lotions, emulsions, essences, lip balms, gels, masks, packs, foundations,
It can be incorporated into various dosage forms such as lipstick, soap, body shampoo, shampoo, rinse, hair restorer, hair styling agent, hair dye, bath agent, toothpaste, mouthwash, adhesive plaster, patch and the like.

【0014】本発明の外用剤には、必要に応じて界面活
性剤(カチオン、アニオン、ノニオン界面活性剤等)、
保湿剤(グリセリン、ポリエチレングリコール、1,3
−ブチレングリコール、乳酸ナトリウム、プルラン、ア
ルギン酸ナトリウム、ピロリドンカルボン酸ナトリウ
ム、キトサン等)、増粘剤(キサンタンガム、マルメロ
種子抽出物、トラガントゴム、プルラン、アルギン酸ナ
トリウム、)、スクワラン等の天然脂質類、油脂(DH
A,EPA、リノール酸、アボガド油、オリーブ油、ゴ
マ油、アーモンド油等)、防腐剤(パラオキシ安息香酸
メチル、パラオキシ安息香酸エチル、パラオキシ安息香
酸プロピル、デヒドロ酢酸ナトリウム、クロロブタノー
ル、ソルビン酸)、紫外線吸収剤、グリチルリチン酸等
の抗炎症剤、鎮痛剤、美白剤(ビタミンC誘導体、アル
ブチン、エラグ酸、コウジ酸、プラセンタエキス、カミ
ツレエキス、ソウハクヒ等)、キレート剤(エデト酸二
ナトリウム)、顔料、抗酸化剤(ビタミンA,E誘導
体、ポリフェノール等)、pH調整剤(クエン酸、リン
酸等の有機酸、アミノ酸等)、薬効成分(αヒドロキシ
酸、DNA,キチン、キトサン、生薬類、ビタミン類、
スフィンゴ糖脂質)、および香料を本発明の目的を達成
する範囲内で0.0001から90%重量の範囲で適宜
配合することができる。
The external preparation of the present invention may contain, if necessary, a surfactant (cation, anion, nonionic surfactant, etc.),
Moisturizer (glycerin, polyethylene glycol, 1,3
-Natural lipids such as butylene glycol, sodium lactate, pullulan, sodium alginate, sodium pyrrolidone carboxylate, chitosan, thickeners (xanthan gum, quince seed extract, tragacanth gum, pullulan, sodium alginate,) squalane, oils and fats ( DH
A, EPA, linoleic acid, avocado oil, olive oil, sesame oil, almond oil, etc., preservatives (methyl parahydroxybenzoate, ethyl paraoxybenzoate, propyl parahydroxybenzoate, sodium dehydroacetate, chlorobutanol, sorbic acid), ultraviolet absorption Agents, anti-inflammatory agents such as glycyrrhizic acid, analgesics, whitening agents (vitamin C derivatives, arbutin, ellagic acid, kojic acid, placenta extract, chamomile extract, soybeans, etc.), chelating agents (disodium edetate), pigments, anti-inflammatory agents Oxidizing agents (vitamin A, E derivatives, polyphenols, etc.), pH adjusters (organic acids such as citric acid, phosphoric acid, amino acids, etc.), medicinal ingredients (α-hydroxy acid, DNA, chitin, chitosan, crude drugs, vitamins,
Glycosphingolipids) and fragrances can be appropriately compounded in a range of 0.0001 to 90% by weight within a range that achieves the object of the present invention.

【0015】浴用剤においては硫酸ナトリウム、炭酸水
素ナトリウム、ホウ砂、色素(黄色202号、アントシ
アニン系天然色素、ウコン色素、紅麹色素等)、保湿剤
(グリセリン、ポリエチレングリコール、1,3−ブチ
レングリコール、乳酸ナトリウム、プルラン、アルギン
酸ナトリウム、ピロリドンカルボン酸ナトリウム、キト
サン等)、有効成分および香料を本発明の目的を達成す
る範囲内で0.0001から90%重量の範囲で適宜配
合し、パウダータイプ、顆粒タイプおよび液剤タイプの
浴用剤を製造することが出来る。
[0015] Bath agents include sodium sulfate, sodium hydrogen carbonate, borax, pigments (Yellow 202, anthocyanin-based natural pigments, turmeric pigments, red koji pigments, etc.) and humectants (glycerin, polyethylene glycol, 1,3-butylene). Glycol, sodium lactate, pullulan, sodium alginate, sodium pyrrolidone carboxylate, chitosan, etc.), an active ingredient and a fragrance in an amount of 0.0001 to 90% by weight within a range that achieves the object of the present invention. , Granule type and liquid type bath preparations can be produced.

【0016】以下本発明の外用剤の実施例と効果試験例
を示す。
Examples of the external preparation of the present invention and test examples of its effects are shown below.

【実施例1】 Embodiment 1

【実施例2】 Embodiment 2

【実施例3】 Embodiment 3

【実施例4】 Embodiment 4

【0017】[0017]

【比較例】(1)比較ローション1 処方例(1)のコメヌカエキス、カンゾウエキス、乳酸
菌醗酵液の代わりに精製水を配合して、全量を調整した
他は処方例(1)に準じて調製した。 (1)比較ローション2 処方例(1)のコメヌカエキス、カンゾウエキスの代わ
りに精製水を配合して、全量を調整した他は、処方例
(1)に準じて調製した。 (1)比較ローション3 処方例(1)のコメヌカエキス、乳酸菌醗酵液の代わり
に精製水を配合して、全量を調整した他は、処方例
(1)に準じて調製した。 (1)比較ローション4 処方例(1)のカンゾウエキス、乳酸菌醗酵液の代わり
に精製水を配合して、全量を調整した他は、処方例
(1)に準じて調製した。 (1)比較ローション5 処方例(1)のコメヌカエキスの代わりに精製水を配合
して、全量を調整した他は、処方例(1)に準じて調製
した。 (1)比較ローション6 処方例(1)のカンゾウエキスの代わりに精製水を配合
して、全量を調整した他は、処方例(1)に準じて調製
した。 (1)比較ローション7 処方例(1)の乳酸菌醗酵液の代わりに精製水を配合し
て、全量を調整した他は、処方例(1)に準じて調製し
た。
[Comparative Example] (1) Comparative lotion 1 Purified water was used in place of the rice bran extract, licorice extract, and fermented lactic acid bacterium of Formulation Example (1), and the whole amount was adjusted. . (1) Comparative lotion 2 Prepared according to Formulation Example (1) except that purified water was mixed in place of the rice bran extract and licorice extract of Formulation Example (1) to adjust the total amount. (1) Comparative lotion 3 Purified water was used instead of the rice bran extract and the lactic acid bacteria fermented solution of Formulation Example (1), and the whole amount was adjusted. (1) Comparative lotion 4 Purified water was used instead of the liquorice extract and lactic acid bacteria fermented solution of Formulation Example (1), and the whole amount was adjusted. (1) Comparative lotion 5 Purified water was used in place of the rice bran extract in Formulation Example (1), and the whole amount was adjusted, except that it was prepared according to Formulation Example (1). (1) Comparative lotion 6 Prepared according to Formulation Example (1) except that purified water was mixed instead of Licorice extract of Formulation Example (1) to adjust the total amount. (1) Comparative lotion 7 Purified water was used instead of the lactic acid bacteria fermented solution of Formulation Example (1), and the whole amount was adjusted, except that it was prepared according to Formulation Example (1).

【0018】色素沈着軽快評価試験 処方例および比較処方例で調製した各種化粧料を色素沈
着が認められた健常人160名のボランティアを20名
ずつ8群に分けて、1群から7群にはそれぞれ比較ロー
ション(1)から(7)の比較ローションを、8群には
処方例(1)の本発明のローションを、朝夕毎日2回、
色素沈着部に使用させて、使用開始後2週間後と4週間
後に色素沈着の軽快程度を表1の判定基準に基づいて評
価した。なお、最終観察期間は使用開始後8週間とし
た。その結果を表2に示したが、本発明の処方例(1)
のローション使用群は比較処方例のいずれの使用群に比
べて皮膚のメラニン色素沈着の軽快傾向が早く現れ、最
終観察時の効果も顕著であることがわかった。
Pigmentation lightening evaluation test Each of the cosmetics prepared in the prescription examples and the comparative prescription examples was divided into 8 groups of 20 healthy volunteers each having 160 pigmented individuals. Each of Comparative Lotions (1) to (7) and the lotion of the present invention of Formulation Example (1) was administered twice daily in the morning and evening to eight groups.
The pigment was used in the pigmented portion, and the degree of remission of pigmentation was evaluated 2 weeks and 4 weeks after the start of use, based on the criteria shown in Table 1. The final observation period was 8 weeks after the start of use. The results are shown in Table 2, and the formulation example (1) of the present invention
It was found that the lotion use group showed a quicker tendency for melanin pigmentation on the skin to appear faster than any of the use groups of the comparative prescription examples, and the effect at the final observation was remarkable.

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 H Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61K 7/00 A61K 7/00 H

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】メラニン生成抑制成剤と抗炎症剤と角質剥
離剤の3成分を同時に配合することを特徴とする外用組
成物。
A composition for external use characterized by simultaneously mixing three components of a melanin production inhibitor, an anti-inflammatory agent and a keratin exfoliating agent.
【請求項2】メラニン生成抑制成剤がコウジ酸、アルブ
チン、ビタミンC及びその誘導体類、エラグ酸、レゾル
シン誘導体、プラセンタエキス、クワエキス、カンゾウ
エキス、コメヌカエキスから選択される単体又は複合物
であり、抗炎症剤がグリチルリチン酸誘導体、インドメ
タシン、アスピリン、アラントイン、カンゾウエキス、
シャクヤクエキス、ゲンチアナエキス、センブリエキ
ス、ニンジンエキスから選択される単体又は複合物であ
り、角質剥離剤がグリコール酸、乳酸、クエン酸、コハ
ク酸、酒石酸、およびそれらの塩類、乳酸菌醗酵液から
選択される単体又は複合物である請求項1の外用組成
物。
2. The melanin production-inhibiting agent is a simple substance or a compound selected from kojic acid, arbutin, vitamin C and its derivatives, ellagic acid, resorcinol derivatives, placenta extract, mulberry extract, licorice extract and rice bran extract. Inflammatory agents are glycyrrhizic acid derivatives, indomethacin, aspirin, allantoin, licorice extract,
Peony extract, gentian extract, assembly extract, or a carrot extract is a simple substance or a complex, and the exfoliating agent is selected from glycolic acid, lactic acid, citric acid, succinic acid, tartaric acid, and salts thereof, and fermented lactic acid bacteria. The composition for external use according to claim 1, which is a simple substance or a composite.
【請求項3】外用組成物が、日焼けによるしみそばかす
を防ぐ又は皮膚のメラニン生成を抑制する又はメラニン
色素を退色化又は消失させ皮膚の美白を目的とした請求
項1の外用組成物。
3. The composition according to claim 1, wherein the composition for external use is for preventing skin spots or freckles due to sunburn, suppressing the production of melanin in the skin, or fading or eliminating the melanin pigment to whiten the skin.
【請求項4】メラニン生成抑制成剤と抗炎症剤と角質剥
離剤を有する3成分を同時に又は24時間以内に皮膚に
塗布することを特徴とする美白方法。
4. A whitening method comprising applying three components comprising a melanin production-inhibiting agent, an anti-inflammatory agent and an exfoliating agent to the skin simultaneously or within 24 hours.
JP2000043474A 2000-01-17 2000-01-17 Composition for external use Pending JP2001199873A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000043474A JP2001199873A (en) 2000-01-17 2000-01-17 Composition for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000043474A JP2001199873A (en) 2000-01-17 2000-01-17 Composition for external use

Publications (1)

Publication Number Publication Date
JP2001199873A true JP2001199873A (en) 2001-07-24

Family

ID=18566387

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000043474A Pending JP2001199873A (en) 2000-01-17 2000-01-17 Composition for external use

Country Status (1)

Country Link
JP (1) JP2001199873A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082227A1 (en) * 2002-03-29 2003-10-09 Sakamoto Bio Co., Ltd. Melanogenesis regulator
JP2004083476A (en) * 2002-08-27 2004-03-18 Horin:Kk Tyrosinase inhibitor, demelanizing agent, fibroblast reproductive factor and estrogenic substance, and skin cosmetic
JP2004137166A (en) * 2002-10-16 2004-05-13 Noevir Co Ltd Skin care preparation for external use, cell activator and antioxidant
JP2005053785A (en) * 2003-05-20 2005-03-03 Nippon Menaade Keshohin Kk External preparation
JP2007182444A (en) * 2006-01-05 2007-07-19 L'oreal Sa Cosmetic use of extract from mentha arvensis
US7429391B2 (en) 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
JP2014505687A (en) * 2011-01-07 2014-03-06 アラーガン、インコーポレイテッド Melanin modified composition and method of use

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082227A1 (en) * 2002-03-29 2003-10-09 Sakamoto Bio Co., Ltd. Melanogenesis regulator
JP2004083476A (en) * 2002-08-27 2004-03-18 Horin:Kk Tyrosinase inhibitor, demelanizing agent, fibroblast reproductive factor and estrogenic substance, and skin cosmetic
JP2004137166A (en) * 2002-10-16 2004-05-13 Noevir Co Ltd Skin care preparation for external use, cell activator and antioxidant
JP2005053785A (en) * 2003-05-20 2005-03-03 Nippon Menaade Keshohin Kk External preparation
US7429391B2 (en) 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
JP2007182444A (en) * 2006-01-05 2007-07-19 L'oreal Sa Cosmetic use of extract from mentha arvensis
JP2014505687A (en) * 2011-01-07 2014-03-06 アラーガン、インコーポレイテッド Melanin modified composition and method of use

Similar Documents

Publication Publication Date Title
JP5093998B2 (en) Pigmentation preventing or improving agent
KR101186081B1 (en) Functional powders
JP2000095663A (en) Agent for external use containing plant extract
JP4091825B2 (en) Skin preparation
JPH0552806B2 (en)
JP5766258B2 (en) Pigmentation preventing or improving agent
JP2000212082A (en) Preparation for external use for skin
WO2013030794A2 (en) Use of substituted pyridines as skin depigmenting compounds
US11918666B2 (en) Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment
JP2001199873A (en) Composition for external use
JP2006249077A (en) External preparation for skin containing phosphorylated sugar
KR20070000675A (en) Composition containing mung bean extract, bletillae tuber extract and black cohosh extract and use thereof
EP3463278B1 (en) Use of thiophosphate derivatives as skin depigmenting agents
JP4857347B2 (en) Skin preparations and hair preparations
JPH08104635A (en) External pharmaceutical preparation containing zinc phytate as active ingredient
JP2008094799A (en) Sulfated glycosaminoglycan production promoter and external preparation for skin containing the same
JP2001131031A (en) Composition for scalp and hair
JP4076477B2 (en) Skin preparation
WO2006022173A1 (en) HUMECTANT CONTAINING α-GLYCOSYL GLYCYRRHIZIN AS ACTIVE INGREDIENT AND USE THEREOF
JPH08310937A (en) Preparation for external use
JP2003113066A (en) Cosmetic
JP2002234828A (en) Skin whitening cosmetic preparation
JP3799340B2 (en) Hydroxytyrosol, application to topical skin preparation
JP2000044459A (en) Skin preparation for external use
JP2000063255A (en) Preparation for external use for skin